These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15294263)

  • 1. Immediate Risk-Stratification Improves Survival (IRIS): study protocol.
    Steinbeck G; Andresen D; Senges J; Hoffmann E; Seidl K; Brachmann J;
    Europace; 2004 Sep; 6(5):392-9. PubMed ID: 15294263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defibrillator implantation early after myocardial infarction.
    Steinbeck G; Andresen D; Seidl K; Brachmann J; Hoffmann E; Wojciechowski D; Kornacewicz-Jach Z; Sredniawa B; Lupkovics G; Hofgärtner F; Lubinski A; Rosenqvist M; Habets A; Wegscheider K; Senges J;
    N Engl J Med; 2009 Oct; 361(15):1427-36. PubMed ID: 19812399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
    Hohnloser SH; Kuck KH; Dorian P; Roberts RS; Hampton JR; Hatala R; Fain E; Gent M; Connolly SJ;
    N Engl J Med; 2004 Dec; 351(24):2481-8. PubMed ID: 15590950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): rationale, design and specific aims.
    Grönefeld G; Connolly SJ; Hohnloser SH;
    Card Electrophysiol Rev; 2003 Dec; 7(4):447-51. PubMed ID: 15071273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking.
    Goldberger JJ; Passman R
    J Am Coll Cardiol; 2009 Nov; 54(22):2001-5. PubMed ID: 19926004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: rationale and design of the Defibrillator After Primary Angioplasty (DAPA) trial.
    Ottervanger JP; Ramdat Misier AR; Zijlstra F; Schalij MJ; Wever E; Jordaens LJ; Henriques JP; de Boer MJ; Robbe HW; Wellens HJ;
    Am Heart J; 2006 Oct; 152(4):636-40. PubMed ID: 16996827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe?
    Santangeli P; Dello Russo A; Casella M; Pelargonio G; Di Biase L; Natale A
    Intern Med J; 2011 Jan; 41(1a):55-60. PubMed ID: 21265961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators.
    Sredniawa B; Mazurek M; Lenarczyk R; Kowalski O; Kowalczyk J; Kalarus Z
    Future Cardiol; 2010 May; 6(3):315-23. PubMed ID: 20462338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI study.
    Atary JZ; Borleffs CJ; Liem SS; Bax JJ; van der Hoeven BL; Bootsma M; van der Wall EE; van Erven L; Schalij MJ
    Europace; 2010 Mar; 12(3):378-84. PubMed ID: 20056593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
    Pietrasik G; Goldenberg I; McNitt S; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML; Wilber DJ; Klein HU;
    J Am Coll Cardiol; 2006 May; 47(9):1811-7. PubMed ID: 16682305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision to implant a cardioverter defibrillator after myocardial infarction: the role of ejection fraction v. other risk factor markers.
    Bailey JJ; Hodges M; Church TR
    Med Decis Making; 2007; 27(2):151-60. PubMed ID: 17409365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.
    Botto GL; Proclemer A; Luzi M; Ruffa F; Gorgoglione MG; Ferrari G
    Ital Heart J; 2005 Mar; 6(3):210-5. PubMed ID: 15875511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of the implantable cardiodefibrillator (ICD) in the prevention of sudden death. Results of evidence based medicine].
    González CM
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-44-S2-46. PubMed ID: 17972377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials.
    Yap YG; Duong T; Bland M; Malik M; Torp-Pedersen C; Køber L; Connolly SJ; Marchant B; Camm J
    Eur Heart J; 2005 Jul; 26(14):1385-93. PubMed ID: 15914501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.